| 书目名称 | Inflammatory Pathways in Diabetes | | 副标题 | Biomarkers and Clini | | 编辑 | Michael Pugia | | 视频video | | | 概述 | Introduces new diagnostic immunological methods for diabetic diseases as potential companion diagnostics, developed in collaboration with leading universities, medical schools, and industrial experts. | | 丛书名称 | Progress in Inflammation Research | | 图书封面 |  | | 描述 | .This book discusses recent advances in new anti- and pro-inflammatory pathways in diabetic disease, and identifies new diagnostic immunological methods that offer potential companion diagnostics for diabetic diseases. New methods in proteomics, mass spectroscopy, immunological assay design, measurement of cellular signal transduction and protease inhibition are used to clarify new biochemical pathways. Biomarker validation in animal models and correlations in humans for diagnostic clinical trials shed new light on the impact of diabetic diseases. The book reviews current understanding of inflammatory pathways in the pathophysiology of insulin resistance, metabolic syndrome, nephritis and other diabetic inflammatory conditions, and is the first to describe the impact of novel adipokines, protease inhibitors and complement markers. By presenting new methodologies for biomarker discovery, it provides a valuable resource for researchers studying clinical diagnosis, drug development, bio-analytical chemistry, proteomics and biochemistry. It is also useful for those conducting clinical and biological studies for targeted drug development. The methodologies and approaches can be applied | | 出版日期 | Book 2015 | | 关键词 | adiponectin receptor; biomarkers; diabetic diseases; diagnostic methods; inflammatory pathways; diabetes; | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-319-21927-1 | | isbn_softcover | 978-3-319-37281-5 | | isbn_ebook | 978-3-319-21927-1Series ISSN 1422-7746 Series E-ISSN 2296-4525 | | issn_series | 1422-7746 | | copyright | Springer International Publishing Switzerland 2015 |
The information of publication is updating
|
|
发表于 2025-3-21 17:25:51
